van Kammen DP - Search Results

1

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.

van Kammen DP, McEvoy JP, Targum SD, Kardatzke D, Sebree TB. van Kammen DP, et al. Psychopharmacology (Berl). 1996 Mar;124(1-2):168-75. doi: 10.1007/BF02245618. Psychopharmacology (Berl). 1996. PMID: 8935813 Clinical Trial.

2

Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia.

Kafka MS, Siever LJ, Nurnberger JI, Uhde TW, Targum S, Cooper DM, van Kammen DP, Tokola NS. Kafka MS, et al. Among authors: van kammen dp. Psychopharmacol Bull. 1985;21(3):599-602. Psychopharmacol Bull. 1985. PMID: 2994161 No abstract available.

3

Dextro-amphetamine diminishes negative symptoms in schizophrenia.

van Kammen DP, Boronow JJ. van Kammen DP, et al. Int Clin Psychopharmacol. 1988 Apr;3(2):111-21. doi: 10.1097/00004850-198804000-00002. Int Clin Psychopharmacol. 1988. PMID: 3294284 Clinical Trial.

4

Amphetamine and negative symptoms of schizophrenia.

Sanfilipo M, Wolkin A, Angrist B, van Kammen DP, Duncan E, Wieland S, Cooper TB, Peselow ED, Rotrosen J. Sanfilipo M, et al. Among authors: van kammen dp. Psychopharmacology (Berl). 1996 Jan;123(2):211-4. doi: 10.1007/BF02246180. Psychopharmacology (Berl). 1996. PMID: 8741946 Clinical Trial.

5

Patient and family attitudes about schizophrenia: implications for genetic counseling.

Schulz PM, Schulz SC, Dibble E, Targum SD, van Kammen DP, Gershon ES. Schulz PM, et al. Among authors: van kammen dp. Schizophr Bull. 1982;8(3):504-13. doi: 10.1093/schbul/8.3.504. Schizophr Bull. 1982. PMID: 7134894

6

Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia.

Yao JK, van Kammen DP, Moss HB, Sokulski DE. Yao JK, et al. Among authors: van kammen dp. Psychiatry Res. 1996 Jul 31;63(2-3):123-32. doi: 10.1016/0165-1781(96)02862-4. Psychiatry Res. 1996. PMID: 8878308

7

Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.

Forman SD, Bissette G, Yao J, Nemeroff CB, van Kammen DP. Forman SD, et al. Among authors: van kammen dp. Schizophr Res. 1994 Apr;12(1):43-51. doi: 10.1016/0920-9964(94)90083-3. Schizophr Res. 1994. PMID: 8018584 Clinical Trial.

8

The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.

van Kammen DP. van Kammen DP. Psychol Med. 1991 Nov;21(4):881-95. doi: 10.1017/s0033291700029871. Psychol Med. 1991. PMID: 1685791 Review.

9

Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.

Gilbertson MW, van Kammen DP. Gilbertson MW, et al. Among authors: van kammen dp. Biol Psychiatry. 1997 Oct 1;42(7):585-95. doi: 10.1016/S0006-3223(96)00435-0. Biol Psychiatry. 1997. PMID: 9376455 Clinical Trial.

10

Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?

van Kammen DP, Hommer DW, Malas KL. van Kammen DP, et al. Neuropsychobiology. 1987;18(3):113-7. doi: 10.1159/000118403. Neuropsychobiology. 1987. PMID: 3453426 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters